Trial intelligence / Profile preview

E2007 in Migraine Prophylaxis

NCT00154063Phase 2Completed

Sponsor
Eisai Co., Ltd.
Start
Jan 2005
Primary completion
Jun 2006
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 2 trial of perampanel in migraine, sponsored by Eisai Co., Ltd.. Started Jan 2005; status: completed.

02

Drugs

perampanel
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00154063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00154063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call